Literature DB >> 29869538

Evaluation of oxidative stress in pseudo-exfoliative glaucoma patients treated with and without topical coenzyme Q10 and vitamin E.

Serdar Ozates1, Kadriye Ufuk Elgin2, Niyazi Samet Yilmaz3, Ozlem Ozbas Demirel4, Emine Sen2, Pelin Yilmazbas2.   

Abstract

PURPOSE: : To evaluate the levels of oxidative stress markers such as superoxide dismutase and malondialdehyde in eyes with pseudo-exfoliative glaucoma treated with and without topical coenzyme Q10 (CQ10) and vitamin E (Coqun drop).
METHODS: : This prospective, randomized clinical study was conducted on 64 eyes of 64 patients. All patients underwent phacoemulsification and intraocular lens implantation surgery. Aqueous humor samples were aspirated from the anterior chamber at the beginning of cataract surgery. The pseudo-exfoliative glaucoma + Coqun group received topical Coqun (100 mg CQ10, 500 mg Vitamin E TPGS) twice daily for 1 month preoperatively, while the pseudo-exfoliative glaucoma group consisted of pseudo-exfoliative glaucoma cases who had not taken Coqun. Pseudo-exfoliation syndrome cases formed the pseudo-exfoliation syndrome group. The main outcomes were the superoxide dismutase and malondialdehyde levels of aqueous humor in both groups.
RESULTS: : The mean aqueous humor superoxide dismutase level was significantly higher in the pseudo-exfoliative glaucoma group than in pseudo-exfoliative glaucoma + Coqun and pseudo-exfoliation syndrome groups (p < 0.001, p = 0.004, respectively). Also, the mean aqueous humor superoxide dismutase level was significantly lower in the pseudo-exfoliation syndrome group than in pseudo-exfoliative glaucoma + Coqun group (p = 0.009). The mean malondialdehyde levels showed no significant difference between the groups (p > 0.05 for all).
CONCLUSION: : Our study showed lower aqueous humor level of superoxide dismutase in pseudo-exfoliation syndrome patients compared to pseudo-exfoliative glaucoma patients. Significantly lower superoxide dismutase level was observed in pseudo-exfoliative glaucoma patients who received topical Coqun compared to pseudo-exfoliative glaucoma patients without Coqun treatment. No significant change was observed on the malondialdehyde level during 1-month follow-up period.

Entities:  

Keywords:  Coenzyme Q10; glaucoma; malondialdehyde; oxidative stress; superoxide dismutase

Mesh:

Substances:

Year:  2018        PMID: 29869538     DOI: 10.1177/1120672118779486

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

Review 1.  Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma.

Authors:  James R Tribble; Flora Hui; Melissa Jöe; Katharina Bell; Vicki Chrysostomou; Jonathan G Crowston; Pete A Williams
Journal:  Cells       Date:  2021-02-01       Impact factor: 6.600

Review 2.  Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain.

Authors:  Haider Manzar; Dalia Abdulhussein; Timothy E Yap; M Francesca Cordeiro
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

Review 3.  Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases.

Authors:  Lara Testai; Alma Martelli; Lorenzo Flori; Arrigo F G Cicero; Alessandro Colletti
Journal:  Nutrients       Date:  2021-05-17       Impact factor: 5.717

4.  Clinical Efficacy of Topical CoQ10 and Vitamin-E Eye-drop in Retinopathy of Prematurity.

Authors:  Muberra Akdogan; Onur Polat
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019-10-01

Review 5.  Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.

Authors:  Lin Fu; Sum Sum Kwok; Yau Kei Chan; Jimmy Shiu Ming Lai; Weihua Pan; Li Nie; Kendrick Co Shih
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 6.  Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma.

Authors:  Annagrazia Adornetto; Laura Rombolà; Luigi Antonio Morrone; Carlo Nucci; Maria Tiziana Corasaniti; Giacinto Bagetta; Rossella Russo
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.